Latest News

The UK medicines regulator (MHRA) has approved EURneffy®, the country’s first needle-free adrenaline nasal spray for the emergency treatment of serious allergic reactions (anaphylaxis) in adults and children weighing 30kg or more. This new option is expected to become available

For anyone living with food allergies—or caring for someone who does—the thought of experiencing a reaction at 30,000 feet can understandably trigger serious worry. People are well aware that help is far from being immediately available in the air, and

Anaphylaxis UK offers our condolences and heartfelt support to the family and friends of Benedict Blythe who was just five years old when he tragically died at school on 1st December 2021. 

Our forums focus on current challenges affecting the food industry in relation to allergens, including recent events, upcoming guidance, and industry challenges.

From 1st to 3rd July, Anaphylaxis UK carried out an impactful visit to the Isle of Man, delivering a series of tailored allergy awareness and training sessions to communities, schools, and healthcare professionals.  

As the weather warms up and we spend more time outdoors, it’s important to take steps to stay safe from insect stings—especially if you or someone you care for is allergic. The good news is that with a few simple precautions, you can still enjoy summer while reducing your risk of being stung.

Anaphylm is a medicine being developed by Aquestive Therapeutics for the emergency treatment of serious allergic reactions, including anaphylaxis.

Now that summer is finally here, it’s important to think about how warmer weather can affect your medications—especially if you have serious allergies. Adrenaline auto-injectors (AAIs) are life-saving devices used to treat serious allergic reactions (anaphylaxis), and they require proper care to work effectively in an emergency. 

Researchers at the University of Southampton are inviting parents and caregivers of young infants to take part in a research study to help prevent food allergy in babies. This research is part of a doctorate project led by Karen Wright,